Levena Biopharma

Triton Algae Innovations is a San Diego-based company that is dedicated to revolutionizing the food industry by providing sustainable and nutritious plant-based protein alternatives. Their innovative approach involves using non-GMO processes to produce vegan plant protein made from algae products, specifically their Hardtii algae, which is rich in protein, amino acids, vitamins, and fatty acids. With a mission to disrupt the unsustainable food ecosystem, Triton aims to offer better nutrition, better health, and better tasting food through their algae-based alternative protein. They have developed a patented process to make their precision fermented algae sustainable and affordable, making them a leading player in the development of microalgae-based ingredients for the future of food.Generated from the website

iBio, Inc. is a biopharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases. It has a pipeline of proprietary products in preclinical development, including sub-unit vaccines directed against both seasonal and pandemic influenza, sub-unit vaccines for prevention of anthrax and plague, sub-unit vaccines for treatment of HPV infections, therapeutic antibodies for treatment of anthrax and antibodies for prevention, treatment and diagnosis of pandemic influenza

Cellics Therapeutics is a San Diego-based biopharmaceutical company that utilizes the innovative Cellular Nanoparticle (CNP) technology to develop nano-therapeutics and advance drug delivery for various substances such as mRNA, siRNA, proteins, and small molecules. Founded by UC San Diego Professor Liangfang Zhang, Cellics leverages two dynamic nanoplatforms, the Cellular Nanosponge and the Cellular Nanoparticle drug delivery technology, which harness the power of cell membranes to create specialized nanoparticle-based therapeutics with the potential to address a wide range of diseases. The Cellular Nanosponge platform consists of a nanoparticle core coated with intact cell membrane, retaining surface protein receptors that mimic innate cells and can act as decoys to bind and neutralize bacterial toxins, cytokines, and viruses. The Cellular Nanoparticle drug delivery technology enables targeted and intracellular delivery of substances, offering high drug loading capacity, targeted drug delivery, intracellular delivery, and potentially improved safety profiles.Generated from the website